Literature DB >> 29256490

Testicular cancer in 2017: Sequencing advances understanding.

Matthew J Murray1, Clare Turnbull2.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29256490     DOI: 10.1038/nrurol.2017.209

Source DB:  PubMed          Journal:  Nat Rev Urol        ISSN: 1759-4812            Impact factor:   14.432


× No keyword cloud information.
  10 in total

1.  Serum Levels of MicroRNA miR-371a-3p: A Sensitive and Specific New Biomarker for Germ Cell Tumours.

Authors:  Klaus-Peter Dieckmann; Arlo Radtke; Meike Spiekermann; Thomas Balks; Cord Matthies; Pascal Becker; Christian Ruf; Christoph Oing; Karin Oechsle; Carsten Bokemeyer; Johannes Hammel; Sebastian Melchior; Werner Wosniok; Gazanfer Belge
Journal:  Eur Urol       Date:  2016-08-02       Impact factor: 20.096

2.  Identification of microRNAs From the miR-371~373 and miR-302 clusters as potential serum biomarkers of malignant germ cell tumors.

Authors:  Matthew J Murray; David J Halsall; C Elizabeth Hook; Denise M Williams; James C Nicholson; Nicholas Coleman
Journal:  Am J Clin Pathol       Date:  2011-01       Impact factor: 2.493

3.  Genetic Determinants of Cisplatin Resistance in Patients With Advanced Germ Cell Tumors.

Authors:  Aditya Bagrodia; Byron H Lee; William Lee; Eugene K Cha; John P Sfakianos; Gopa Iyer; Eugene J Pietzak; Sizhi Paul Gao; Emily C Zabor; Irina Ostrovnaya; Samuel D Kaffenberger; Aijazuddin Syed; Maria E Arcila; Raju S Chaganti; Ritika Kundra; Jana Eng; Joseph Hreiki; Vladimir Vacic; Kanika Arora; Dayna M Oschwald; Michael F Berger; Dean F Bajorin; Manjit S Bains; Nikolaus Schultz; Victor E Reuter; Joel Sheinfeld; George J Bosl; Hikmat A Al-Ahmadie; David B Solit; Darren R Feldman
Journal:  J Clin Oncol       Date:  2016-09-30       Impact factor: 44.544

4.  Genomic evolution and chemoresistance in germ-cell tumours.

Authors:  Amaro Taylor-Weiner; Travis Zack; Elizabeth O'Donnell; Jennifer L Guerriero; Brandon Bernard; Anita Reddy; G Celine Han; Saud AlDubayan; Ali Amin-Mansour; Steven E Schumacher; Kevin Litchfield; Clare Turnbull; Stacey Gabriel; Rameen Beroukhim; Gad Getz; Scott L Carter; Michelle S Hirsch; Anthony Letai; Christopher Sweeney; Eliezer M Van Allen
Journal:  Nature       Date:  2016-11-30       Impact factor: 49.962

5.  Identification of 19 new risk loci and potential regulatory mechanisms influencing susceptibility to testicular germ cell tumor.

Authors:  Kevin Litchfield; Max Levy; Giulia Orlando; Chey Loveday; Philip J Law; Gabriele Migliorini; Amy Holroyd; Peter Broderick; Robert Karlsson; Trine B Haugen; Wenche Kristiansen; Jérémie Nsengimana; Kerry Fenwick; Ioannis Assiotis; ZSofia Kote-Jarai; Alison M Dunning; Kenneth Muir; Julian Peto; Rosalind Eeles; Douglas F Easton; Darshna Dudakia; Nick Orr; Nora Pashayan; D Timothy Bishop; Alison Reid; Robert A Huddart; Janet Shipley; Tom Grotmol; Fredrik Wiklund; Richard S Houlston; Clare Turnbull
Journal:  Nat Genet       Date:  2017-06-12       Impact factor: 38.330

Review 6.  The present and future of serum diagnostic tests for testicular germ cell tumours.

Authors:  Matthew J Murray; Robert A Huddart; Nicholas Coleman
Journal:  Nat Rev Urol       Date:  2016-10-18       Impact factor: 14.432

7.  Whole-exome sequencing reveals the mutational spectrum of testicular germ cell tumours.

Authors:  Kevin Litchfield; Brenda Summersgill; Shawn Yost; Razvan Sultana; Karim Labreche; Darshna Dudakia; Anthony Renwick; Sheila Seal; Reem Al-Saadi; Peter Broderick; Nicholas C Turner; Richard S Houlston; Robert Huddart; Janet Shipley; Clare Turnbull
Journal:  Nat Commun       Date:  2015-01-22       Impact factor: 14.919

8.  Rare disruptive mutations in ciliary function genes contribute to testicular cancer susceptibility.

Authors:  Kevin Litchfield; Max Levy; Darshna Dudakia; Paula Proszek; Claire Shipley; Sander Basten; Elizabeth Rapley; D Timothy Bishop; Alison Reid; Robert Huddart; Peter Broderick; David Gonzalez de Castro; Simon O'Connor; Rachel H Giles; Richard S Houlston; Clare Turnbull
Journal:  Nat Commun       Date:  2016-12-20       Impact factor: 14.919

9.  Meta-analysis of five genome-wide association studies identifies multiple new loci associated with testicular germ cell tumor.

Authors:  Zhaoming Wang; Katherine A McGlynn; Ewa Rajpert-De Meyts; D Timothy Bishop; Charles C Chung; Marlene D Dalgaard; Mark H Greene; Ramneek Gupta; Tom Grotmol; Trine B Haugen; Robert Karlsson; Kevin Litchfield; Nandita Mitra; Kasper Nielsen; Louise C Pyle; Stephen M Schwartz; Vésteinn Thorsson; Saran Vardhanabhuti; Fredrik Wiklund; Clare Turnbull; Stephen J Chanock; Peter A Kanetsky; Katherine L Nathanson
Journal:  Nat Genet       Date:  2017-06-12       Impact factor: 38.330

10.  Accurate primary germ cell cancer diagnosis using serum based microRNA detection (ampTSmiR test).

Authors:  Ton van Agthoven; Leendert H J Looijenga
Journal:  Oncotarget       Date:  2016-07-27
  10 in total
  2 in total

1.  Clinical utility of circulating miR-371a-3p for the management of patients with intracranial malignant germ cell tumors.

Authors:  Matthew J Murray; Thankamma Ajithkumar; Fiona Harris; Rachel M Williams; Ibrahim Jalloh; Justin Cross; Milind Ronghe; Dawn Ward; Cinzia G Scarpini; James C Nicholson; Nicholas Coleman
Journal:  Neurooncol Adv       Date:  2020-04-13

2.  Lymph Node Ratio Rather Than Positive Lymph Node Counts Has Better Prognostic Value in Patients With Testicular Germ Cell Tumors.

Authors:  Chuyang Huang; Qian Long; Yangxun Pan; Leilei Wu; Xiaonan Wang; Hailin Xu; Fufu Zheng
Journal:  Technol Cancer Res Treat       Date:  2021 Jan-Dec
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.